ROLE OF DYSFUNCTIOINAL DOPAMINERGIC SYSTEM ON PATHOGENESIS OF POLYCYSTIC OVARIAN SYNDROME

功能障碍的多巴胺能系统在多囊卵巢综合征发病机制中的作用

基本信息

项目摘要

The dopaminergic system was studied in patients with polycystic ovarian syndrome(PCOS), and also in rat's ovary in vitro by the stimulation of dopamine-agonists. LH, FSH and PRL were measured before and after 3 months administration of bromocriptine in patients with various types of PCOS. LH and PRL were dramatically decreased in every type of PCOS, while FSH remained normal. The depletion of responses of LH and PRL to LHRH and TRH was observed, however, the response of FSH showed no remarkable cliange. 80% of PCOS ovulated in response to the bromocriptine treatment, and about 30-50% of patients became pregnant in every type of PCOS. Moreover, little ovarian hyperstimulation syndrome was pointed out in present study, which was often complicated with the usual methods of the induction of ovulation in PCOS. These facts indicate that the dysfunction of the dopaminergic activity is one of the cause of PCOS, and that the replacement therapy by the dopaminergic agonists is rational treatment of PCOS. The rat's granulosa cells and luteal cells were cultured in the medium with the dopaminergic agonists. Both granulosa and luteal cells increased progesterone and 20 alpha OH-progesterone production by the dopaminergic agonist, which were indifferent with cAMP accumulation. This facts suggest that replaced dopamine effected on the ovaries not on the hypothalmopituitary area, which required further experiments.
本实验研究了多囊卵巢综合征(PCOS)患者及离体大鼠卵巢多巴胺能系统的变化。方法:对10例不同类型的PCOS患者在服用溴隐亭3个月前后分别测定LH、FSH和PRL。各型PCOS患者LH、PRL均明显下降,FSH正常。LH和PRL对LHRH和TRH的反应性降低,而FSH的反应性无明显变化。80%的PCOS患者对溴隐亭治疗有排卵反应,每种类型的PCOS患者中约有30-50%的患者怀孕。此外,本研究还指出,PCOS患者的卵巢过度刺激综合征很少发生,常与常规促排卵方法并发。提示多巴胺能功能障碍是多囊卵巢综合征的病因之一,多巴胺能受体激动剂替代治疗是多囊卵巢综合征的合理治疗方法。将大鼠颗粒细胞和黄体细胞培养在含有多巴胺能激动剂的培养基中。颗粒细胞和黄体细胞增加孕酮和20 α OH-孕酮生产的多巴胺能激动剂,这是无关紧要的cAMP积累。这一事实表明,替代多巴胺对卵巢的影响而不是对下丘脑垂体区的影响,这需要进一步的实验。

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
友成廉平,松岡良,友成美鈴,吉松淳,森宏之: "HMG-HCG療法にたいするBromocriptive併用の効果" 日本不妊学会雑誌. 34. 1-5 (1989)
Renpei Tomonari、Ryo Matsuoka、Misuzu Tomonari、Jun Yoshimatsu、Hiroyuki Mori:“Bromocriptive 联合使用对 HMG-HCG 治疗的效果”日本不孕症协会杂志 34. 1-5 (1989)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
MORI,H: "Role of Prolactin in Human Reproduction" Karger(Basel), 313 (1988)
MORI,H:“催乳素在人类生殖中的作用”Karger(巴塞尔),313(1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
森宏之: "月経異常の臨床" 新興医学出版社(東京), 96 (1988)
Hiroyuki Mori:“月经异常的临床临床研究”Shinko Igaku Shuppansha(东京),96(1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Mori H: "Clinical Basis of Menstrual Disturbances" Shinkou Igaku Shuppanaha, Tokyo, 1988.
Mori H:“月经失调的临床基础”Shinkou Igaku Shuppanaha,东京,1988 年。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Mori H: "Effects of Bromocriptine on Infertile Women with Normoprolactinemia:Clinical Usefulness of Bromocriptine and Its Underlying Mechanism" in Human Reproduction. Current Status/Future Prospect, 247-249, Elsevier, Amsterdam, 1988.
Mori H:“溴隐亭对患有正泌乳素血症的不孕妇女的影响:溴隐亭及其潜在机制在人类生殖中的临床用途”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MORI Hiroyuki其他文献

PiXie Analysis for Monitoring Dynamic Protein Interaction and Folding in a Living Cell
用于监测活细胞中动态蛋白质相互作用和折叠的 PiXie 分析
  • DOI:
    10.2142/biophys.61.036
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    MIYAZAKI Ryoji;MORI Hiroyuki;AKIYAMA Yoshinori
  • 通讯作者:
    AKIYAMA Yoshinori

MORI Hiroyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MORI Hiroyuki', 18)}}的其他基金

Developmental disorder traits and social capital in association with depression/quality of life in elementary and middle school students.
发育障碍特征和社会资本与中小学生抑郁/生活质量的关系。
  • 批准号:
    20K14043
  • 财政年份:
    2020
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Prevention, Compensation and Relief Policy for Asbestos Disaster and International Relations
石棉灾害的预防、补偿、救济政策与国际关系
  • 批准号:
    15H01757
  • 财政年份:
    2015
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Degradation mechanisms of sigma 32 by membrane targeting via SRP pathway
通过 SRP 途径膜靶向降解 sigma 32 的机制
  • 批准号:
    23657128
  • 财政年份:
    2011
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Studies on Calculation of a Set of the Pareto Solutions for Multi-objective Optimization in Transmission Network Expansion Planning with the Uncertainties
含不确定性的输电网络扩容规划多目标优化帕累托解集计算研究
  • 批准号:
    23560342
  • 财政年份:
    2011
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SecDF function and roles of the proton motive force in protein translocation
SecDF 的功能以及质子动力在蛋白质易位中的作用
  • 批准号:
    22370070
  • 财政年份:
    2010
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Static and dynamical properties characteristic to Bose-Fermi atoms on optical lattices
光学晶格上玻色费米原子的静态和动态特性
  • 批准号:
    21540410
  • 财政年份:
    2009
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structural analysis of SecA-SecYE complex from Thermus thermophilus
嗜热栖热菌 SecA-SecYE 复合物的结构分析
  • 批准号:
    19370085
  • 财政年份:
    2007
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Highly Accurate Short-term Electric Load Forecasting in Consideration of Equalization of Learning Data
考虑学习数据均衡的高精度短期电力负荷预测
  • 批准号:
    16560257
  • 财政年份:
    2004
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on Highly accurate Short-term Electric Power Load Forecasting with Fuzzy Data Mining
模糊数据挖掘高精度短期电力负荷预测研究
  • 批准号:
    13650319
  • 财政年份:
    2001
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on a Load Forecasting Method with the Evolutionary Parallel Algorithm
一种进化并行算法的负荷预测方法研究
  • 批准号:
    09650331
  • 财政年份:
    1997
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Phase 2 Kp-10 for Dopamine Agonist Intolerant Hyperprolactinemia IND 74,977
多巴胺激动剂不耐受高催乳素血症 2 期 Kp-10 IND 74,977
  • 批准号:
    10116170
  • 财政年份:
    2018
  • 资助金额:
    $ 0.26万
  • 项目类别:
A novel rodent model of dopamine agonist-induced impulsive control disorders
多巴胺激动剂诱导的冲动控制障碍的新型啮齿动物模型
  • 批准号:
    8093443
  • 财政年份:
    2011
  • 资助金额:
    $ 0.26万
  • 项目类别:
A novel rodent model of dopamine agonist-induced impulsive control disorders
多巴胺激动剂诱导的冲动控制障碍的新型啮齿动物模型
  • 批准号:
    8288065
  • 财政年份:
    2011
  • 资助金额:
    $ 0.26万
  • 项目类别:
Long-term non-fluctuating dopamine agonist delivery for Parkinson's disease
长期非波动多巴胺激动剂治疗帕金森病
  • 批准号:
    8113878
  • 财政年份:
    2010
  • 资助金额:
    $ 0.26万
  • 项目类别:
Long-term non-fluctuating dopamine agonist delivery for Parkinson's disease
长期非波动多巴胺激动剂治疗帕金森病
  • 批准号:
    8001701
  • 财政年份:
    2010
  • 资助金额:
    $ 0.26万
  • 项目类别:
Dopamine system and sleep-wake regulation : molecular mechanisms of dopamine agonist induced sleep
多巴胺系统和睡眠-觉醒调节:多巴胺激动剂诱导睡眠的分子机制
  • 批准号:
    19591381
  • 财政年份:
    2007
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inhaled dopamine agonist for late stage Parkinsonism
吸入多巴胺激动剂治疗晚期帕金森病
  • 批准号:
    6586957
  • 财政年份:
    2003
  • 资助金额:
    $ 0.26万
  • 项目类别:
TRITIUM LABELLING OF DOPAMINE AGONIST: SCHIZOPHRENIA
多巴胺激动剂的氚标记:精神分裂症
  • 批准号:
    6500519
  • 财政年份:
    2000
  • 资助金额:
    $ 0.26万
  • 项目类别:
TRITIUM LABELLING OF DOPAMINE AGONIST: SCHIZOPHRENIA
多巴胺激动剂的氚标记:精神分裂症
  • 批准号:
    6220446
  • 财政年份:
    1998
  • 资助金额:
    $ 0.26万
  • 项目类别:
INTRAVENOUS DOPAMINE AGONIST THERAPY--PARKINSONS DISEASE
静脉多巴胺激动剂治疗--帕金森病
  • 批准号:
    2379734
  • 财政年份:
    1996
  • 资助金额:
    $ 0.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了